Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $7,829,539 (100.0% shares, 0.0% debt)

Holdings (12)

MRNA Moderna Inc 61.8%

Value ($000) $4,836,127 Shares 20,581,016 Est. Cost $16.43 Unrealized +987.5%

— Rubius Therapeutics Inc 12.0%

Value ($000) $939,945 Shares 38,506,526 Est. Cost $24.00 Unrealized —

SANA Sana Biotechnology Inc 8.6%

Value ($000) $673,139 Shares 34,239,018 Est. Cost $32.56 Unrealized -30.4%

— Seres Therapeutics Inc 4.4%

Value ($000) $342,935 Shares 14,378,802 Est. Cost $8.55 Unrealized —

— Evelo Biosciences Inc 4.0%

Value ($000) $316,433 Shares 23,030,069 Est. Cost $10.39 Unrealized —

DNLI Denali Therapeutics Inc 2.7%

Value ($000) $214,162 Shares 2,730,263 Est. Cost $17.97 Unrealized +244.2%

KLDO Kaleido Biosciences Inc 1.9%

Value ($000) $145,643 Shares 19,575,710 Est. Cost $13.01 Unrealized -45.5%

FHTX Foghorn Therapeutics Inc 1.7%

Value ($000) $135,233 Shares 12,674,120 Est. Cost $19.16 Unrealized -43.1%

— Sigilon Therapeutics Inc 1.4%

Value ($000) $111,274 Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Axcella Health Inc 0.6%

Value ($000) $50,319 Shares 12,548,414 Est. Cost $8.17 Unrealized —

— Codiak Biosciences Inc 0.6%

Value ($000) $48,314 Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Syros Pharmaceuticals Inc 0.2%

Value ($000) $16,015 Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	20,581,016	$4,836,127	61.8%	$16.43	+987.5%	COM	60770K107
—	Rubius Therapeutics Inc	38,506,526	$939,945	12.0%	$24.00	—	COM	78116T103
SANA	Sana Biotechnology Inc	34,239,018	$673,139	8.6%	$32.56	-30.4%	COM	799566104
—	Seres Therapeutics Inc	14,378,802	$342,935	4.4%	$8.55	—	COM	81750R102
—	Evelo Biosciences Inc	23,030,069	$316,433	4.0%	$10.39	—	COM	299734103
DNLI	Denali Therapeutics Inc	2,730,263	$214,162	2.7%	$17.97	+244.2%	COM	24823R105
KLDO	Kaleido Biosciences Inc	19,575,710	$145,643	1.9%	$13.01	-45.5%	COM	483347100
FHTX	Foghorn Therapeutics Inc	12,674,120	$135,233	1.7%	$19.16	-43.1%	COM	344174107
—	Sigilon Therapeutics Inc	10,370,369	$111,274	1.4%	$48.03	—	COM	82657L107
—	Axcella Health Inc	12,548,414	$50,319	0.6%	$8.17	—	COM	05454B105
—	Codiak Biosciences Inc	2,607,303	$48,314	0.6%	$32.30	—	COM	192010106
—	Syros Pharmaceuticals Inc	2,938,494	$16,015	0.2%	$13.87	—	COM	87184Q107